Entera Bio Ltd. · NASDAQ:ENTX

Entera Bio Ltd. financial statements

Entera Bio Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue42.0K181.0K0134.0K571.0K365.0K
Cost of revenue42.0K172.0K0101.0K373.0K300.0K
Gross profit09.00K033.0K198.0K65.0K
Research and development6.00M4.50M4.51M5.85M6.77M6.38M
Selling, general and administrative398.0K340.0K
Operating income-11.5M-9.59M-8.89M-13.0M-12.2M-11.2M
Depreciation and amortization30.0K46.0K56.0K64.0K53.0K63.0K
EBITDA-11.5M-9.54M-8.84M-13.0M-12.2M-11.1M
Income before tax-11.4M-9.53M-8.86M-12.9M-12.2M-11.2M
Income tax014.0K29.0K137.0K-59.0K20.0K
Net income-11.4M-9.54M-8.89M-13.1M-12.2M-11.2M
Earnings per share, basic0.250.250.310.450.470.67
Earnings per share, diluted0.250.250.310.450.470.67

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents7.11M8.66M11.0M12.3M24.9M8.59M
Receivables0126.0K0246.0K183.0K255.0K
Current assets15.3M8.97M11.3M12.8M25.3M9.11M
Property, plant and equipment134.0K57.0K100.0K139.0K156.0K192.0K
Total assets16.0M9.39M11.8M13.1M26.0M9.72M
Accounts payable448.0K132.0K83.0K17.0K166.0K164.0K
Current liabilities2.20M1.18M1.09M1.34M3.16M1.84M
Total liabilities2.89M1.31M1.38M1.37M3.42M2.21M
Shareholders' equity13.1M8.08M10.4M11.8M22.6M7.51M
Shares outstanding46.2M38.8M35.5M28.8M28.8M21.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-7.37M-6.82M-7.31M-12.5M-9.06M-10.6M
Capital spending-107.0K-3.00K-17.0K-47.0K-17.0K-53.0K
Free cash flow-7.48M-6.82M-7.33M-12.5M-9.08M-10.6M
Cash from investing-107.0K-3.00K-17.0K-102.0K-17.0K-53.0K
Cash from financing13.7M4.48M6.04M13.0K25.4M4.05M
Change in cash6.20M-2.35M-1.29M-12.6M16.3M-6.56M